CJMB

Callan JMB Inc. Common Stock

CJMB

Market cap $23.2M

Overview Fund Activity

5.18 USD

-0.02

0.38%

At close Updated Sep 12, 4:00 PM EDT

1 day

-0.38%

5 days

11.88%

1 month

9.51%

3 months

9.98%

6 months

11.16%

Year to date

26.34%

1 year

26.34%

5 years

26.34%

10 years

26.34%

About: Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how. It provides a system that utilizes predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.

Employees: 26

Industrials Integrated Freight & Logistics

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

29% more funds holding

Funds holding: 7 [Q1] → 9 (+2) [Q2]

16% more capital invested

Capital invested by funds: $3.11M [Q1] → $3.59M (+$485K) [Q2]

0.19% more ownership

Funds ownership: 15.58% [Q1] → 15.77% (+0.19%) [Q2]

See Fund Rankings

Financial journalist opinion

Callan JMB to Participate in Upcoming September Conferences

SPRING BRANCH, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that management will participate in the following September 2025 investment conferences.

Callan JMB to Participate in Upcoming September Conferences

Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

Formed a strategic partnership with Revival Health Inc. (“Revival”) to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of health, wellness, and longevity products

Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding

Contract Increase Extends Seven-Year Partnership through June 2026 with Price Increase of $1.5 Million to Total Value of $9.1 Million

Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding

Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines

Callan JMB redistributed more than 1,300 vaccine doses using its specialized cold chain reusable shippers from Westside CDC in Chicago to Texas and New Mexico, ensuring no vaccines went to waste

Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines

Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update

Completed Initial Public Offering (IPO) on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option

Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update

Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs

Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries.

Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs

Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option

Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

Callan JMB to Participate in Upcoming March Conferences

SPRING BRANCH, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced that management will participate in the following March 2025 investor conferences.

Callan JMB to Participate in Upcoming March Conferences

Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations

SPRING BRANCH, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced a new comprehensive lease program for vaccine management that will enable government agencies and private organizations to provide crucial immunizations without the economic burden of purchasing the necessary equipment outright.

Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations

Callan JMB Announces Partial Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering

SPRING BRANCH, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced that the underwriters of its previously announced initial public offering of shares of its common stock (“Common Stock”) have partially exercised their over-allotment option, resulting in the issuance of an additional 163,569 shares of Common Stock (the “Option Shares” or “Share”) at a public offering price of $4.00 per Share for additional gross proceeds of $654,276. After giving effect to the partial exercise of the over-allotment option, an aggregate of 1,443,569 shares of Common Stock have been issued in the initial public offering (the “Offering”) for aggregate net proceeds of approximately $4,729,319.78, after deducting underwriting discounts, commissions and offering expenses payable by the Company.

Callan JMB Announces Partial Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering

See News Rankings

Charts implemented using Lightweight Charts™